表紙
市場調査レポート

腫瘍マーカー市場:器具および試薬サプライヤーのシェア、国別予測、競合分析、機会

Tumor Markers 2016-2020: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

発行 Venture Planning Group 商品コード 200911
出版日 ページ情報 英文 1200 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。

Local License: 同一事業所内

Back to Top
腫瘍マーカー市場:器具および試薬サプライヤーのシェア、国別予測、競合分析、機会 Tumor Markers 2016-2020: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
出版日: ページ情報: 英文 1200 Pages
概要

腫瘍診断と治療における画期的技術開発が行われており、新たな抗原の発見などによって、癌診断市場は爆発的拡大が期待されています。今後10年で、世界の癌診断市場は大きく成長する見込みです。

当レポートは、米国、欧州、日本における腫瘍マーカー市場の動向、新興の診断技術の応用、国別腫瘍マーカー売上予測、主要企業のプロファイルとともに、今後10年の腫瘍マーカー市場の動向とビジネスの機会をまとめ、概略下記の内容でお届けいたします。

イントロダクション

世界市場と技術概要

  • 癌の統計と病因
  • 現在および新興の腫瘍マーカー
  • 装置レビューと市場のニーズ
  • 現在および新興の診断技術
  • 競合・補完技術
  • ビジネス環境
  • 市場構造
  • 個別検査

フランス

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模、成長、主要サプライヤー

ドイツ

イタリア

日本

スペイン

英国

米国

主な製品開発の機会

  • 試薬キット、検査システム/パネル
  • 装置
  • コンピュータ、ソフトウェア、自動化
  • 補助製品

分散検査製品の設計基準

代替的市場浸透戦略

  • 社内開発
  • 提携契約
  • 大学との提携
  • 流通戦略
    • マーケティングアプローチ
    • 製品の複雑性
    • 顧客の嗜好
    • 老舗サプライヤー
    • 新興のサプライヤー
    • 販売業者の種類
    • 市場セグメンテーション

市場参入障壁とリスク

  • 市場の成熟
  • 費用抑制
  • 競合
  • 技術力と限界
  • 特許の保護
  • 法規制の制約
  • 市場の課題

競合プロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPTM18441

Highlights

- Identifies and evaluates major business opportunities emerging in the tumor marker market
during the next five years
- Examines trends in the U.S., Europe and Japan
- Reviews current and emerging tumor markers
- Analyzes applications of emerging diagnostic technologies
- Forecasts sales of major tumor markers by country and market segment
- Profiles leading market players and potential entrants
- Suggests alternative business expansion strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.  During the next ten years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA

Market Segmentation Analysis

- Sales and market shares of major suppliers, by individual tumor marker
and country.

- Five-year test volume and sales forecasts for major
tumor markers by country and market segment,
including:

- Hospitals
- Commercial/Private Laboratories
- Physician Offices/Group Practices
- Cancer Clinics
- Ambulatory Care Centers

- Comprehensive market segmentation analysis, including review
of the market dynamics, structure, size, growth and major suppliers
by country.

- Cancer statistics, etiology and recent developments in the
U.S., Japan and five major European countries.

Current and Emerging Products

- Review of over 200 current and emerging tumor markers,
including:

- Biochemical Markers
- Oncogenes
- Growth Factors
- Hormones
- Colony Stimulating Factors
- Lymphokines
- Immunohistochemical Stains, and others.

- Analysis of major immunoassay analyzers used for
tumor marker testing, including their operating characteristics,
features and selling prices.

Technology Review

- Assessment of monoclonal antibodies, immunoassays, DNA
probes, biochips/microarrays, chromosome analysis, IT,
artificial intelligence, flow cytometry, biosensors, and their
potential applications for tumor marker testing.

- Review of competing/complementing technologies, including
CT, MRI, NMR, PET and photonics spectroscopy.

- Extensive listings of over 500 companies, universities and
research centers developing new tumor markers and detection technologies.

Competitive Assessments

- Extensive strategic assessments of  major suppliers
and start-up firms developing innovative
technologies and products, including their sales,
product portfolios, marketing tactics, collaborative
arrangements and new products in R&D.

Worldwide Market Overview

- Estimated universe of laboratories performing tumor marker testing
by country.

- Ten-year test volume and sales projections by country.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially
significant market appeal during the next ten years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Methodology

This report is based on interviews with clinical pathologists, laboratory directors,
executives from leading diagnostic companies and start-up firms
developing innovative products, university scientists, as well as
experts from industry associations, venture capital firms and the
investment banking community in the U.S., five major European
countries and Japan.

The market projections are also based on questionnaire
responses received from hospitals, commercial/private laboratories,
physician offices/group practices, cancer clinics and ambulatory
care centers in seven countries.

In addition to primary sources of information, a comprehensive
review of the most recent technical and business publications, manufacturer
product literature, patents, trade association surveys, government
studies, marketing and technical meeting presentations,
industry analyst reports, and VPGMarketResearch's proprietary data files was conducted. 

Contains: 1,200 pages and 450 tables.

Table of Contents

I. Introduction

II. Worldwide Market Overview

III. Major Product Development Opportunities

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies

VI. Potential Market Entry Barriers and Risks

VII. Worldwide Market and Technology Overview

  • A. Cancer Statistics and Etiology
  • B. Major Current And Emerging Cancer Diagnostic Tests
  • C. Biochemical Tumor Markers
  • D. Oncogenes
  • E. Polypeptide Growth Factors
  • 1. Ectopic Hormones
  • 2. Colony Stimulating Factors
  • F. Lymphokines
  • G. Immunohistochemical Stains
  • H. Emerging Tumor Markers
  • I. Instrumentation Review And Market Needs
  • J. Current and Emerging Technologies
  • K. Personal Testing

VIII. France

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

IX. Germany

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

X. Italy

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

XI. Japan

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

XII. Spain

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

XIII. U.K.

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

XIV. U.S.A.

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

List of Tables

  • Tumor Marker Classification
  • Major Companies Developing or Marketing ACTH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing Beta-2 Microglobulin Tests
  • Major Companies Developing or Marketing CA 15-3/27.29 Tests
  • Major Companies Developing or Marketing CA 19-9 Tests
  • Major Companies Developing or Marketing CA 125 Tests
  • Major Companies Developing or Marketing Calcitonin Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Estrogen Receptor Tests
  • Major Companies Developing or Marketing Progesterone Receptor Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Gastrin Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing Insulin Tests
  • Major Companies Developing or Marketing NSE Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing PAP Smear/HPV Tests
  • Major Companies Developing or Marketing PAP Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing
  • Lymphocyte Subclassification Tests
  • Biochemical Markers Potential Applications In Cancer Diagnosis
  • Oncogenes Potential Applications In Cancer Diagnosis
  • Major Companies Developing or Marketing Oncogene Tests
  • Growth Factors Potential Applications In Cancer Diagnosis
  • Colony Stimulating Factors Potential Applications in Cancer Diagnosis
  • Lymphokines Potential Applications In Cancer Diagnosis Immunohistochemical Stains Potential
  • Applications in Cancer Diagnosis
  • Executive Summary Table: France, Total Cancer Diagnostic Test Volume and Sales Forecast by Market Segment
  • France, Estimated Cancer Death Rates Per 100,000 Population
  • France, Laboratories Performing Tumor Marker Tests by Market Segment
  • France, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • France, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • France, Total Tumor Marker Test Volume Forecast by Market Segment
  • France, All Market Segments Major Tumor Marker Test Volume Forecast
  • France, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
  • France, Commercial/Private Laboratories Marker Test Volume Forecast
  • France, Total Tumor Marker Sales Major Tumor Forecast by Market Segment
  • France, All Market Segments Major Tumor Marker Sales Forecast by Test
  • France, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • France, Commercial/Private Laboratories Cancer Diagnostics Market Forecast by Test
  • France, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market
  • France, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
  • France, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment
  • France, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
  • France, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, S-100 Protein Test Volume and Sales Diagnostics Sales Forecast by Market Segment
  • France, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Thymidine Kinase Test Volume And Diagnostics Sales Forecast by Market Segment
  • France, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Total Tumor Marker Sales By Major Suppliers
  • France, AFP Testing Market Diagnostics Sales by Major Supplier
  • France, CA 15-3 Testing Market Diagnostics Sales by Major Supplier
  • France, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • France, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • France, CEA Testing Market Diagnostics Sales by Major Supplier
  • France, NSE Testing Market Diagnostics Sales by Major Supplier
  • France, PAP Testing Market Diagnostics Sales by Major Supplier
  • France, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Germany, Total Tumor Marker Test Volume and Sales Forecast By Market Segment
  • Germany, Estimated Cancer Death Rates Per 100,000 Population
  • Germany, Laboratories Performing Tumor Marker Tests by Market Segment
  • Germany, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Germany, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • Germany, Total Tumor Marker Test Volume Forecast by Market Segment
  • Germany, All Market Segments, Major Tumor Marker Test Volume Forecast
  • Germany, Hospital Laboratories, Major Tumor Marker Test Volume Forecast by Test
  • Germany, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Germany, Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
  • Germany, Total Tumor Marker Sales Forecast by Market Segment
  • Germany, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Germany, Hospital Laboratories, Major Tumor Marker Sales Forecast by Test
  • Germany, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Germany, Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
  • Germany, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecast by Market Segment
  • Germany, CA-15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CA-19 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Calcitonin Test Volume And Diagnostic Sales Forecast by Market Segment
  • Germany, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Chromogranin Test Volume And Diagnostics Sales Forecast by Market Segment
  • Germany, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
  • Germany, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, HCG, Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Pap Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
  • Germany, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
  • Germany, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Total Tumor Marker Sales By Major Supplier
  • Germany, AFP Testing Market Diagnostics Sales by Major Supplier
  • Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Germany, CEA Testing Market Diagnostics Sales by Major Supplier
  • Germany, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Italy, Total Tumor Marker Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Estimated Cancer Death Rates Per 100,000 Population
  • Italy, Laboratories Performing Tumor Marker Tests by Market Segment
  • Italy, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Italy, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • Italy, Total Tumor Marker Test Volume Forecast by Market Segment
  • Italy, All Market Segments Major Cancer Diagnostic Test Volume Forecast
  • Italy, Hospital Laboratories Major Tumor Marker Test Volume Forecast
  • Italy, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Italy, Total Tumor Marker Test Market Forecast by Market Segment
  • Italy, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Italy, Hospital Laboratories Major Tumor Marker Forecast by Test
  • Italy, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Italy, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecast by Market Segment
  • Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, CA-19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Chromogranin Test Volume And Diagnostics Sales Forecast by Market Segment
  • Italy, Colon Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
  • Italy, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment
  • Italy, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
  • Italy, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, S-100 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
  • Italy, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Total Tumor Markers Sales by Major Suppliers
  • Italy, AFP Testing Market Diagnostics Sales by Major Supplier
  • Italy, CEA Testing Market Diagnostics Sales by Major Supplier
  • Italy, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Japan, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
  • Japan, Estimated Cancer Death Rates Per 100,000 Population
  • Japan, Laboratories Performing Tumor Marker Tests by Market Segment
  • Japan, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Japan, Commercial/Private Laboratories Performing Tumor Marker Tests By Annual Test Volume
  • Japan, Total Tumor Marker Testing Volume Forecast by Market Segment
  • Japan, All Market Segments Major Tumor Marker Test Volume Forecast
  • Japan, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
  • Japan, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Japan, Total Tumor Marker Sales Forecast by Market Segment
  • Japan, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Japan, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • Japan, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Japan, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
  • Japan, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, TPA, Test Volume and Diagnostics Sales Forecast by Market Segment `
  • Japan, Total Tumor Marker Sales by Major Suppliers
  • Japan, AFP Testing Market Diagnostics Sales by Major Supplier
  • Japan, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Japan, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Japan, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Japan, Calcitonin Testing Market Diagnostics Sales by Major Supplier
  • Japan, PAP Testing Market Diagnostics Sales by Major Supplier
  • Japan, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Spain, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
  • Spain, Estimated Cancer Death Rates Per 100,000 Population
  • Spain, Laboratories Performing Tumor Marker Tests by Market Segment
  • Spain, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Spain, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • Spain, Total Tumor Marker Test Volume Forecast by Market Segment
  • Spain, All Market Segment Major Cancer Diagnostic Test Volume Forecast
  • Spain, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecast by Test
  • Spain, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Spain, Total Tumor Marker Sales Forecast by Market Segment
  • Spain, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Spain, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • Spain, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Spain, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CA 15-3 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Parathyroid Hormone Test Volume And Diagnostics Sales Forecast by Market Segment
  • Spain, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, S-100 Protein Test Volume And Diagnostics Sales Forecast by Market Segment
  • Spain, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Total Tumor Marker Sales by Major Suppliers
  • Spain, AFP Testing Market Diagnostics Sales by Major Supplier
  • Spain, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Spain, 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Spain, CEA Testing Market Diagnostics Sales by Major Supplier
  • Spain, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: U.K., Total Tumor Marker Test Volume and Sales Forecast by Market Segment
  • U.K., Estimated Cancer Death Rates Per 100,000 Population
  • U.K., Laboratories Performing Tumor Marker Tests by Market Segment
  • U.K., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • U.K., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume
  • U.K., Total Tumor Marker Testing Volume Forecast by Market Segment
  • U.K., All Market Segments Major Tumor Marker Test Volume Forecast
  • U.K., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
  • U.K., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • U.K., Total Tumor Marker Sales Forecast by Market Segment
  • U.K., All Market Segments Major Tumor Marker Sales Forecast by Test
  • U.K., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • U.K., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • U.K., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Colon-Specific Antigen Test Volume And Diagnostics Sales by Market Segment
  • U.K., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Total Tumor Marker Sales and Market Shares Forecast
  • U.K., CEA Testing Market Diagnostics Sales by Major Supplier
  • U.K., PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: U.S., Total Tumor Marker Test Volume and Sales Forecast By Market Segment
  • U.S., Estimated New Cancer Cases and Deaths
  • U.S., Estimated Cancer Death Rates Per 100,000 Population
  • U.S., Laboratories Performing Tumor Marker Tests by Market Segment
  • U.S., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • U.S., Commercial/Private Laboratories Performing Tumor Marker Tests By Annual Test Volume
  • U.S., Physician Office Laboratories Performing Tumor Marker Tests By Practice Size
  • U.S., Total Tumor Marker Test Volume Forecast by Market Segment
  • U.S., All Market Segments Major Tumor Marker Test Volume Forecast
  • U.S., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
  • U.S., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • U.S., Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
  • U.S., Cancer Clinics Major Tumor Marker Test Volume Forecast by Test
  • U.S., Total Tumor Marker Sales Forecast by Market Segment
  • U.S., All Market Segment Major Tumor Marker Sales Forecast by Test
  • U.S., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • U.S., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • U.S., Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
  • U.S., Cancer Clinics Major Tumor Marker Sales Forecast by Test
  • U.S., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., CEA Test Volume and Diagnostics Sales by Market Segment
  • U.S., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Colon-specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
  • U.S., Cytokeratins Test Volume And Diagnostics Sales Forecast by Market Segment
  • U.S., Estrogen Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
  • U.S., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Interferons Test Volume And Diagnostics Sales Forecast by Market Segment
  • U.S., Interleukins Test Volume And Diagnostics Sales Forecast by Market Segment
  • U.S., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Occult Blood Test Volume And Diagnostics Sales Forecast by Market Segment
  • U.S., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Total Tumor Marker Sales By Major Supplier
  • U.S., ACTH Testing Market Diagnostics Sales by Major Supplier
  • U.S., AFP Testing Market Diagnostics Sales by Major Supplier
  • U.S., Beta-2 Migroblolulin Testing Market Diagnostics Sales by Major Supplier
  • U.S., CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • U.S., CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • U.S., CA 125 Testing Market Diagnostics Sales by Major Supplier
  • U.S., CEA Testing Market Diagnostics Sales by Major Supplier
  • U.S., Ferritin Testing Market Diagnostics Sales by Major Supplier
  • U.S., HCG Testing Market Diagnostics Sales by Major Supplier
  • U.S., Insulin Testing Market Diagnostics Sales by Major Supplier
  • U.S., Parathyroid Hormone Testing Market Diagnostics Sales by Major Supplier
  • U.S., PAP Testing Market Diagnostics Sales by Major Supplier
  • U.S., Progesterone Receptor Testing Market Diagnostics Sales by Major Supplier
  • U.S., PSA Testing Market Diagnostics Sales by Major Supplier
Back to Top